In 2024, Italy's business expenditure on R&D in human health activities is forecasted at 331.43 million euros, showing an upward trend from prior years. The annual rise indicates consistent growth with a forecast of 397.45 million euros by 2028. Over this 5-year period, we anticipate a compounded annual growth rate (CAGR) illustrating a steady commitment to advancing health research.
Looking ahead, potential trends to monitor include:
- Government policies and incentives shifting the R&D landscape.
- Technological advancements driving efficiency and innovation.
- Increasing collaboration between public and private sectors.
